Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05195489 · ClinicalTrials.gov registry record · NA

Examining the Impact of Family Connectors

A NA study of Caregiver Stress Syndrome, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
28
Enrollment target
1
Study location

NCT05195489 is a NA study of Caregiver Stress Syndrome that has completed, run by NYU Langone Health. The registered enrollment target is 28 participants, below the 258-participant average among 3 other Caregiver Stress Syndrome trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05195489, a NA study of Caregiver Stress Syndrome, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
28 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to understand the impact of Family Connectors, a peer-to-peer support and education program for family members who have participated in OnTrackNY, a treatment program for adolescents and young adults.

Conditions Studied

Interventions

  • OTHER Family Connectors

Study Locations (1)

New York

  • NYU Langone Health - New York

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2022-03-07
Est. Completion 2024-11-11
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT05195489

The ClinicalTrials.gov registry entry for NCT05195489 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 258-participant average among 3 other Caregiver Stress Syndrome trials with a reported enrollment target (89% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Caregiver Stress Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Family Connectors is the first listed.

NCT05195489 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05195489 about?

NCT05195489 is a clinical study titled "Examining the Impact of Family Connectors". The purpose of this study is to understand the impact of Family Connectors, a peer-to-peer support and education program for family members who have participated in OnTrackNY, a treatment program for adolescents and young adults.

What is the current status of trial NCT05195489?

This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2022-03-07. Estimated completion is 2024-11-11.

What conditions does trial NCT05195489 study?

This clinical trial studies the following conditions: Caregiver Stress Syndrome.

What interventions are being tested in trial NCT05195489?

The interventions under investigation include: Family Connectors (OTHER).

Who is sponsoring clinical trial NCT05195489?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05195489 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Caregiver Stress Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.